About us

Since its foundation in 2004, the MVZ HPH Institute for Pathology and Hematopathology Hamburg, Germany, has established itself as a fixture in the German healthcare system. From the very beginning, our mission has been to actively shape the diagnostic landscape and turn scientific progress into clinical practice for the benefit of the patient.

Our diagnostic range covers leukemia, lymphoma and solid tumors, as well as benign hematologic and lymphatic disorders. To provide hematologists and oncologists with the best possible support when making therapy decisions, more than 300 employees ensure diagnostics are performed quickly, reliably and to the highest quality standards.

Capabilities

• **Histology**: Conventional histology for tissue analysis
• **Cytomorphology**: Examination of individual cells and small cell groups
• **Immunohistochemistry (IHC)**: Detection of specific cellular structures
• **NGS-based Molecular Diagnostics**: Comprehensive genetic analysis
• **Bioinformatics**: Analysis of complex biomarkers
• **Digital Pathology & AI**: Innovative technologies strengthening diagnostic capabilities
• **Immunophenotyping (FACS)**: Flow cytometry for precise cell differentiation